GE HealthCare has received FDA Premarket Authorization for Pristina Recon DL, an innovative 3D mammography reconstruction application. Powered by artificial intelligence (AI), Pristina Recon DL ...
GE Healthcare, a unit of General Electric Company, announced the US Food & Drug Administration (FDA) 510(k) clearance of an innovative technology to aid the physician in breast cancer diagnosis. GE ...
Amid technologist shortage, new mammography innovation was designed through intensive collaboration with technologists will help to streamline workflow and humanize care CHICAGO, November 26, ...
CHICAGO--(BUSINESS WIRE)--Today GE HealthCare announced the new Pristina Via™* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results